Iavi
Iavi
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Iavi? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
Iavi is a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges including HIV and tuberculosis. Our mission is to translate scientific discoveries into affordable, accessible public health solutions for the people who need them most.
About
Research and development: Through scientific and clinical research in Africa, India, Europe, and the U.S., Iavi develops vaccines and antibodies in and for the developing world and seeks to accelerate their introduction in low-income countries. Iavi advances scientific discovery and development by fostering unique collaborations among academia, industry, local communities, governments, and funders to explore new and better ways to address public health threats that disproportionately affect people living in poverty. Vaccine and antibody candidates are put through a rigorous process of clinical evaluation among key populations to establish their safety and efficacy, an effort that enables Iavi to strengthen the healthcare infrastructure and scientific capacity of countries where our clinical partners operate. To date, Iavi and its partners have advanced more than 30 HIV vaccine candidates into early stage clinical trials. This includes the first HIV vaccine trials in sub-Saharan countries, where the HIV burden is greatest. Iavi has conducted 47 epidemiological studies and provided voluntary HIV testing and counseling services to more than 790,000 individuals in Africa. Iavi also supports preclinical development and clinical testing of vaccine candidates for other diseases, including tuberculosis and Lassa fever, as well as antibody candidates for disease prevention and treatment. Iavi conducts trials with the highest scientific and ethical standards to protect the rights, well-being, and dignity of trial volunteers. Iavi has also launched research consortia to address major scientific problems of biomedical product development. A significant portion of the research Iavi supports is conducted in developing countries where the need for infectious disease prevention is greatest.
Interesting data from their 2019 990 filing
The non-profit's aim, as stated in the filing, is “A nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges including hiv and tuberculosis. the organization's mission is to translate scientific discoveries into affordable, globally accessible public health solutions.”.
When referring to its actions, they were outlined as: “Translate scientific discoveries into affordable, globally accessible public health solutions”.
- The non-profit has complied with legal obligations by reporting their state of operation as DE.
- The non-profit's address in 2019 is noted in the filing as 125 BROAD STREET NO 9TH FL, NEW YORK, NY, 10004.
- The non-profit's form for 2019 reports a total of 196 employees.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is -$6,190,277.
- The organization has 14 independent voting members.
- The organization was formed in 1996.
- The organization pays $29,819,824 in salary, compensation, and benefits to its employees.
- The organization pays $1,234,999 in fundraising expenses.